Nitinol Devices & Components has successfully completed the acquisition of Interface Catheter Solutions. Reflecting the combination’s expanded strategic breadth, NDC and Interface will create Confluent Medical Technologies,the leading contract manufacturer of specialized medical devices.
Nitinol Devices & Components, Inc.
The combined company will leverage the technical expertise of both NDC and Interface in highly precise and demanding medical devices. Additionally, the complementary technology platforms create a unique opportunity to deepen relationships with the existing customer base, particularly in the endovascular, neurovascular, transcatheter heart valve, peripheral vascular, ENT and orthopedic markets.
Interface, a pioneer in medical balloon technology, is the leading contract manufacturer of balloon catheter systems. The company combines best-in-class balloon design and development, high-quality balloon contract manufacturing and deep equipment manufacturing expertise to serve a broad array of medical device customers. Interface specializes in ultra-high-pressure, high-pressure, textured surface and jumbo balloons in addition to full balloon catheter assemblies. The company’s optimized extrusion capabilities, supporting balloon contract manufacturing, produces the highest quality and highest reliability extrusions available in the market.
The combination represents a significant step forward in providing fully integrated solutions to medical device customers. Confluent Medical’s portfolio of services includes:
- Nitinol component contract manufacturing
- Balloon component contract manufacturing
- Balloon catheter assembly contract manufacturing
- Nitinol core guidewire contract manufacturing
- Nitinol device design and testing services
- Balloon catheter design and testing services
- Balloon manufacturing equipment
- Nitinol material
- Extrusion
“The acquisition of Interface reflects our commitment to investing in material science technologies that enable us to best serve the medical device community. The NDC-Interface combination is an excellent strategic fit and we are excited to leverage the key talent and technical expertise of the combined companies to provide world class, differentiated products to our customers,” said Dean Schauer President & CEO.
Tom Duerig, CEO commented, “It has long been a goal of NDC to apply its manufacturing, quality systems and technical expertise beyond Nitinol, broadening the manufacturing and outsourcing solutions we can offer to customers. The exceptional technical strength of Interface with polymers, catheters and balloons provides the perfect opportunity to accomplish just that.”
Nitinol Devices & Components
www.nitinol.com
Interface Catheter Solutions
www.interfaceusa.com
